4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001209191-21-021320
Chief Operating Officer sold 6,250 shares at $29.43 ($183,951)
- Chief Operating Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
FORD KATHLEEN · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 1 in the form | +6,250 | $19.43 | $121,438 | 6,250 | D |
| 2021-03-15 | Sale : show line 2 in the form | −6,250 | $29.43 | $183,951 | 0 | D |
| Open-market sales · 6,250 sh · avg $29.43 · $183,951 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 3 in the form Option to purchase common stock | −6,250 | $19.43 | 2029-08-08 | 6,250 | 215,625 | D |
Loading xslF345X03/doc4.xml…